Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus

Rheumatology International

Volumn 32, Issue 2, 2012, Pages 395-402

  Ma, Chun Yan ^a   Jiao, Yu Lian ^a   Zhang, Jie ^a   Yang, Qing Rui ^a   Zhang, Zhi Fen ^a   Shen, Ya Juan ^a   Chen, Zi Jiang ^a   Zhao, Yue Ran ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

High mobility group box protein 1; Interferon alpha; Systemic lupus erythematosus; Tumor necrosis factor alpha

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; C REACTIVE PROTEIN; DOUBLE STRANDED DNA ANTIBODY; HIGH MOBILITY GROUP B1 PROTEIN; NUCLEOSOME ANTIBODY; SM ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; CHILD; FEMALE; HMGB1 PROTEIN; HUMANS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84857039916     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1636-6     Document Type: Article

References (39)

1. CC Mock CS Lau 2003 Pathogenesis of systemic lupus erythematosus J Clin Pathol 56 481 490 10.1136/jcp.56.7.481 (Pubitemid 36819418)
2. TB Niewold J Hua TJ Lehman, et al. 2007 High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus Genes Immun 8 492 502 17581626 10.1038/sj.gene.6364408 1:CAS:528:DC%2BD2sXpvFWgtL8%3D (Pubitemid 47365615)
3. C Gota L Calabrese 2003 Induction of clinical autoimmune disease by therapeutic interferon-alpha Autoimmunity 36 511 518 14984028 10.1080/08916930310001605873 (Pubitemid 37498247)
4. M Feldmann RN Maini 2001 Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 19 163 196 11244034 10.1146/annurev. immunol.19.1.163 1:CAS:528:DC%2BD3MXivFKgtbg%3D (Pubitemid 32368033)
5. A Studnicka-Benke G Steiner P Petera, et al. 1996 Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus Br J Rheumatol 35 1067 1074 8948291 10.1093/rheumatology/35.11.1067 1:STN:280:DyaK2s7gsVWhtw%3D%3D
6. M Aringer JS Smolen 2008 The role of tumor necrosis factor-alpha in systemic lupus erythematosus Arthritis Res Ther 10 202 18226185 10.1186/ar2341 (Pubitemid 352044828)
7. J Li H Xie T Wen, et al. 2010 Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus J Rheumatol 37 766 775 20110525 10.3899/jrheum.090663 1:CAS:528:DC%2BC3cXmtFCru7o%3D
8. JO Thomas AA Travers 2001 HMG1 and 2, and related 'architectural' DNA-binding proteins Trends Biochem Sci 26 167 174 11246022 10.1016/S0968- 0004(01)01801-1 1:CAS:528:DC%2BD3MXhs1elsrg%3D (Pubitemid 32197576)
9. ME Bianchi A Agresti 2005 HMG proteins: dynamic players in gene regulation and differentiation Curr Opin Genet Dev 15 496 506 16102963 10.1016/j.gde.2005.08.007 1:CAS:528:DC%2BD2MXpvFenur4%3D (Pubitemid 41262405)
10. P Scaffidi T Misteli ME Bianchi 2002 Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 418 191 195 12110890 10.1038/nature00858 1:CAS:528:DC%2BD38XltFGlsro%3D (Pubitemid 34773774)
11. H Wang O Bloom M Zhang, et al. 1999 HMG-1 as a late mediator of endotoxin lethality in mice Science 285 248 251 10398600 10.1126/science.285.5425.248 1:CAS:528:DyaK1MXks1Sjtb0%3D (Pubitemid 29329996)
12. MT Lotze KJ Tracey 2005 High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal Nat Rev Immunol 5 331 342 15803152 10.1038/nri1594 1:CAS:528:DC%2BD2MXivVarsr8%3D (Pubitemid 40516158)
13. E Abraham J Arcaroli A Carmody, et al. 2000 HMG-1 as a mediator of acute lung inflammation J Immunol 165 2950 2954 10975801 1:CAS:528: DC%2BD3cXmslyns7g%3D
14. JS Park F Gamboni-Robertson Q He, et al. 2006 High mobility group box 1 protein interacts with multiple Toll-like receptors Am J Physiol Cell Physiol 290 C917 C924 16267105 10.1152/ajpcell.00401.2005 1:CAS:528:DC%2BD28Xjt1Slu7g%3D
15. U Andersson H Wang K Palmblad, et al. 2000 High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes J Exp Med 192 565 570 10952726 10.1084/jem.192.4.565 1:CAS:528:DC%2BD3cXlvFemsL0%3D (Pubitemid 30666257)
16. JS Park D Svetkauskaite Q He, et al. 2004 Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein J Biol Chem 279 7370 7377 14660645 10.1074/jbc.M306793200 1:CAS:528: DC%2BD2cXhsFaqurc%3D (Pubitemid 38294612)
17. R Kokkola E Sundberg AK Ulfgren, et al. 2002 High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis Arthritis Rheum 46 2598 2603 12384917 10.1002/art.10540 1:CAS:528:DC%2BD38XovVWitrw%3D (Pubitemid 36118922)
18. N Taniguchi K Kawahara K Yone, et al. 2003 High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine Arthritis Rheum 48 971 981 12687539 10.1002/art.10859 1:CAS:528:DC%2BD3sXjtlKnsrk%3D (Pubitemid 36418239)
19. R Pullerits IM Jonsson M Verdrengh, et al. 2003 High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis Arthritis Rheum 48 1693 1700 12794838 10.1002/art.11028 1:CAS:528:DC%2BD3sXltlSgu7s%3D (Pubitemid 36682378)
20. R Kokkola J Li E Sundberg, et al. 2003 Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity Arthritis Rheum 48 2052 2058 12847700 10.1002/art.11161 1:CAS:528:DC%2BD3sXmtFartbc%3D (Pubitemid 36828701)
21. A Yoshizaki K Komura Y Iwata, et al. 2009 Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity J Clin Immunol 29 180 189 18825489 10.1007/s10875-008-9252-x 1:CAS:528:DC%2BD1MXis12htbg%3D
22. K Popovic M Ek A Espinosa, et al. 2005 Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus Arthritis Rheum 52 3639 3645 16255056 10.1002/art.21398 1:CAS:528:DC%2BD2MXht1KrurzO (Pubitemid 41612235)
23. M Ek K Popovic HE Harris, et al. 2006 Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjogren's syndrome Arthritis Rheum 54 2289 2294 16802368 10.1002/art.21969 1:CAS:528:DC%2BD28XnslKhu7k%3D (Pubitemid 44051086)
24. J Tian AM Avalos SY Mao, et al. 2007 Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE Nat Immunol 8 487 496 17417641 10.1038/ni1457 1:CAS:528:DC%2BD2sXkt1Khtro%3D (Pubitemid 46605917)
25. IE Dumitriu P Baruah ME Bianchi, et al. 2005 Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells Eur J Immunol 35 2184 2190 15915542 10.1002/eji.200526066 1:CAS:528:DC%2BD2MXmvVeju7Y%3D (Pubitemid 41015057)
26. X Qing M Pitashny DB Thomas, et al. 2008 Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury Immunol Lett 121 61 73 18822317 10.1016/j.imlet.2008.08.007 1:CAS:528:DC%2BD1cXht12lsbfI
27. MC Hochberg 1997 Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 40 1725 9324032 10.1002/art.1780400928 1:STN:280:DyaK2svmsVaisw%3D%3D
28. LH Sigal 2007 Basic science for the clinician 42: handling the corpses: apoptosis, necrosis, nucleosomes and (quite possibly) the immunopathogenesis of SLE J Clin Rheumatol 13 44 48 17278952 10.1097/01.rhu.0000256288.09733.22 (Pubitemid 46213845)
29. A Midgley Z McLaren RJ Moots, et al. 2009 The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus Arthritis Rheum 60 2390 2401 19644848 10.1002/art.24634 1:CAS:528:DC%2BD1MXhtV2hsLnE
30. G Liu J Wang YJ Park, et al. 2008 High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine J Immunol 181 4240 4246 18768881 1:CAS:528:DC%2BD1cXhtVKntbvO
31. V Urbonaviciute BG Furnrohr S Meister, et al. 2008 Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE J Exp Med 205 3007 3018 19064698 10.1084/jem.20081165 1:CAS:528:DC%2BD1MXosFCl
32. P Rovere-Querini A Capobianco P Scaffidi, et al. 2004 HMGB1 is an endogenous immune adjuvant released by necrotic cells EMBO Rep 5 825 830 15272298 10.1038/sj.embor.7400205 1:CAS:528:DC%2BD2cXmtFOhur8%3D (Pubitemid 39199174)
33. L Bennett AK Palucka E Arce, et al. 2003 Interferon and granulopoiesis signatures in systemic lupus erythematosus blood J Exp Med 197 711 723 12642603 10.1084/jem.20021553 1:CAS:528:DC%2BD3sXitlOgs74%3D (Pubitemid 36350866)
34. KA Kirou C Lee S George, et al. 2005 Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease Arthritis Rheum 52 1491 1503 15880830 10.1002/art.21031 1:CAS:528:DC%2BD2MXkvFCisr8%3D (Pubitemid 40663941)
35. M Iannacone G Sitia M Isogawa, et al. 2008 Platelets prevent IFN-alpha/beta-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus Proc Natl Acad Sci USA 105 629 634 18184798 10.1073/pnas.0711200105 1:CAS:528:DC%2BD1cXpvV2ruw%3D%3D (Pubitemid 351171759)
36. A Yamane T Nakamura H Suzuki, et al. 2008 Interferon-alpha 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes Blood 112 542 550 18523149 10.1182/blood-2007-12-125906 1:CAS:528:DC%2BD1cXpsVajur0%3D
37. AK Palucka JP Blanck L Bennett, et al. 2005 Cross-regulation of TNF and IFN-alpha in autoimmune diseases Proc Natl Acad Sci USA 102 3372 3377 15728381 10.1073/pnas.0408506102 1:CAS:528:DC%2BD2MXitl2lur0%3D (Pubitemid 40328052)
38. HM Lee T Mima H Sugino, et al. 2009 Interactions among type I and type II interferon, tumor necrosis factor, and beta-estradiol in the regulation of immune response-related gene expressions in systemic lupus erythematosus Arthritis Res Ther 11 R1 19121222 10.1186/ar2584
39. G Grondal I Gunnarsson J Ronnelid, et al. 2000 Cytokine production, serum levels and disease activity in systemic lupus erythematosus Clin Exp Rheumatol 18 565 570 11072595 1:STN:280:DC%2BD3crhsVKktg%3D%3D